Rockville, MD, USA—Companies marketing regulated healthcare products such as pharmaceuticals, medical devices and biologics must stay up to date on the complex and rapidly changing regulatory environment governing promotional efforts and labeling. On Thursday, 8 September, the Regulatory Affairs Professionals Society (RAPS) will hold a daylong virtual workshop examining this important topic. Expert presenters will provide insight into the latest regulations, enforcement actions, guidelines and trends affecting advertising, promotion and labeling of healthcare products.
The comprehensive workshop, entitled Advertising, Promotion and Labeling: Marketing in a Regulated Environment will be led by Bradley Merrill Thompson, JD, MBA, RAC, attorney, Epstein Becker & Green PC.
“The regulations pertaining to marketing medicines and medical products are in place to keep patients and healthcare professionals appropriately and accurately informed, and failure to comply can deal a serious blow to a company’s bottom line. So it is critically important for both business and public health reasons for regulatory professionals to clearly understand the rules and precedents,” said Thompson. “This workshop will help attendees better understand the complex issues involved and the implications of the latest developments affecting advertising, promotion and labeling.”
The workshop will cover relevant regulations from US agencies, including the US Food and Drug Administration (FDA) and the Federal Trade Commission (FTC), as well as European regulatory authorities, and how they impact communications with consumers, healthcare professionals and patient groups. Topics to be covered include claims substantiation, testimonials and the use of social media.
Members of the working media may request access to this live virtual workshop or to the recording by contacting Zachary Brousseau, senior manager, communications, RAPS, at zbrousseau@raps.org or +1 301 770 2920, ext. 245.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org
